Viewing Study NCT06394232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-01-03 @ 4:43 AM
Study NCT ID: NCT06394232
Status: RECRUITING
Last Update Posted: 2024-09-24
First Post: 2024-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Sponsor: Eyestem Research Pvt. Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Retinal Disease View
None Macular Degeneration View
None Age-Related Macular Degeneration View
None Geographic Atrophy View
None Eye Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age Related Macular Degeneration View
None Geographic Atrophy View
None Visual Impairment View
None Subretinal injection View
None Stem cells View
None Retinal Pigment Epithelial Cells View